May 9, 2019 – Stereotaxis introduced Stereotaxis Genesis RMN, its next-generation...
Robotic electrophysiology operating room including Stereotaxis Genesis RMN and Stereotaxis Imaging Model S systems. Image courtesy of Stereotaxis.
News | Robotic Systems | May 09, 2019
News | EP Mapping and Imaging Systems | May 09, 2019
May 9, 2019 — Philips announced a collaboration with Medtronic to further advance treatment of...
News | Ablation Systems | May 08, 2019
May 8, 2019 — Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new...
Sponsored Content
Feature | Sudden Cardiac Arrest | October 25, 2018
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to...
Khaldoon Alaswad, M.D., FSCAI, right, during a chronic total occlusion (CTO) case in his lab at Henry Ford Hospital, Detroit. He is presenting in several SCAI 2019 sessions.
Feature | SCAI | May 08, 2019
May 8, 2019 — The Society for Cardiovascular Angiography and...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
May 7, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...
Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, where the AI takes 3-D datasets and automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard echocardiogram views to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.
Feature | Artificial Intelligence | May 07, 2019 | Ross Upton
Artificial Intelligence has a multitude of impacts on our daily lives, from recommending movies based upon your...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree image showing the main hybrid cath lab at ...
Technology | Leads Implantable Devices | May 06, 2019
May 6, 2019 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad...
According to the National Association of County and City Health Officials, only 33 percent of the organizations plan against cybersecurity threats and initiate patient identity protection protocols.
Feature | Cybersecurity | May 06, 2019 | Maxim Chernyak
As the...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
News | Implantable Cardiac Monitor (ICM) | May 06, 2019
May 6, 2019 — Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive...
Illustration showing the self-expanding deployment of the Vici stent in the iliofemoral vein.
Technology | Venous Therapies | May 06, 2019
May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System...
Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM.
Technology | Heart Failure | May 06, 2019
May 6, 2019 — The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (...
